Cell-permeable, Small-molecule Activators of the Insulin-degrading Enzyme

Overview

Journal J Biomol Screen

Publisher Sage Publications

Date 2012 Jun 29

PMID 22740246

Citations 6

Authors

Sayali S Kukday

Surya P Manandhar

Marissa C Ludley

Mary E Burriss

Benjamin J Alper

Walter K Schmidt

Affiliations

Soon will be listed here.

Abstract

The insulin-degrading enzyme (IDE) cleaves numerous small peptides, including biologically active hormones and disease-related peptides. The propensity of IDE to degrade neurotoxic Aβ peptides marks IDE as a potential therapeutic target for Alzheimer disease. Using a synthetic reporter based on the yeast a-factor mating pheromone precursor, which is cleaved by multiple IDE orthologs, we identified seven small molecules that stimulate rat IDE activity in vitro. Half-maximal activation of IDE by the compounds is observed in vitro in the range of 43 to 198 µM. All compounds decrease the K(m) of IDE. Four compounds activate IDE in the presence of the competing substrate insulin, which disproportionately inhibits IDE activity. Two compounds stimulate rat IDE activity in a cell-based assay, indicating that they are cell permeable. The compounds demonstrate specificity for rat IDE since they do not enhance the activities of IDE orthologs, including human IDE, and they appear specific for a-factor-based reporters since they do not enhance rat IDE-mediated cleavage of Aβ-based reporters. Our results suggest that IDE activators function in the context of specific enzyme-substrate pairs, indicating that the choice of substrate must be considered in addition to target validation in IDE activator screens.

Citing Articles

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.

Tundo G, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A Biomolecules. 2023; 13(10).

PMID: 37892174 PMC: 10604886. DOI: 10.3390/biom13101492.

Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition.

Liang W, Wijaya J, Wei H, Noble A, Mancl J, Mo S Nat Commun. 2022; 13(1):1833.

PMID: 35383169 PMC: 8983764. DOI: 10.1038/s41467-022-29322-4.

Resveratrol Sustains Insulin-Degrading Enzyme Activity toward Aβ42.

Krasinski C, Ivancic V, Zheng Q, Spratt D, Lazo N ACS Omega. 2018; 3(10):13275-13282.

PMID: 30411033 PMC: 6210067. DOI: 10.1021/acsomega.8b01913.

Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides.

Hildebrandt E, Arachea B, Wiener M, Schmidt W J Biol Chem. 2016; 291(27):14185-14198.

PMID: 27129777 PMC: 4933176. DOI: 10.1074/jbc.M116.718197.

Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.

Charton J, Gauriot M, Totobenazara J, Hennuyer N, Dumont J, Bosc D Eur J Med Chem. 2014; 90:547-67.

PMID: 25489670 PMC: 4325277. DOI: 10.1016/j.ejmech.2014.12.005.

References

Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

Tam A, Schmidt W, Michaelis S . The multispanning membrane protein Ste24p catalyzes CAAX proteolysis and NH2-terminal processing of the yeast a-factor precursor. J Biol Chem. 2001; 276(50):46798-806. DOI: 10.1074/jbc.M106150200. View

Farias 3rd M, Gorman M, Savage M, Feigl E . Plasma ATP during exercise: possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol. 2004; 288(4):H1586-90. DOI: 10.1152/ajpheart.00983.2004. View

Porter S, Hildebrandt E, Breevoort S, Mokry D, Dore T, Schmidt W . Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. Biochim Biophys Acta. 2007; 1773(6):853-62. PMC: 1976251. DOI: 10.1016/j.bbamcr.2007.03.004. View

Kim M, Hersh L, Leissring M, Ingelsson M, Matsui T, Farris W . Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J Biol Chem. 2007; 282(11):7825-32. DOI: 10.1074/jbc.M609168200. View

Barstead R, Waterston R . The basal component of the nematode dense-body is vinculin. J Biol Chem. 1989; 264(17):10177-85. View

Zagorski M, Yang J, Shao H, Ma K, Zeng H, Hong A . Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol. 1999; 309:189-204. DOI: 10.1016/s0076-6879(99)09015-1. View

Michaelis S, Herskowitz I . The a-factor pheromone of Saccharomyces cerevisiae is essential for mating. Mol Cell Biol. 1988; 8(3):1309-18. PMC: 363277. DOI: 10.1128/mcb.8.3.1309-1318.1988. View

Kim S, Lapham A, Freedman C, Reed T, Schmidt W . Yeast as a tractable genetic system for functional studies of the insulin-degrading enzyme. J Biol Chem. 2005; 280(30):27481-90. DOI: 10.1074/jbc.M414192200. View

10.

Kaur M, Reed E, Sartor O, Dahut W, Figg W . Suramin's development: what did we learn?. Invest New Drugs. 2002; 20(2):209-19. DOI: 10.1023/a:1015666024386. View

11.

Chen P, Sapperstein S, Choi J, Michaelis S . Biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor. J Cell Biol. 1997; 136(2):251-69. PMC: 2134810. DOI: 10.1083/jcb.136.2.251. View

12.

Shen Y, Joachimiak A, Rosner M, Tang W . Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature. 2006; 443(7113):870-4. PMC: 3366509. DOI: 10.1038/nature05143. View

13.

Im H, Manolopoulou M, Malito E, Shen Y, Zhao J, Neant-Fery M . Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem. 2007; 282(35):25453-63. DOI: 10.1074/jbc.M701590200. View

14.

Holbeck S . Update on NCI in vitro drug screen utilities. Eur J Cancer. 2004; 40(6):785-93. DOI: 10.1016/j.ejca.2003.11.022. View

15.

Song E, Juliano M, Juliano L, Fried M, Wagner S, Hersh L . ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. J Biol Chem. 2004; 279(52):54216-20. DOI: 10.1074/jbc.M411177200. View

16.

Kwak J, Wang M, Hwang S, Kim T, Lee S, Oh U . Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains. J Neurosci. 2000; 20(22):8298-304. PMC: 6773187. View

17.

Chan R, Otte C . Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol. 1982; 2(1):11-20. PMC: 369748. DOI: 10.1128/mcb.2.1.11-20.1982. View

18.

Miller B, Eckman E, Sambamurti K, Dobbs N, Chow K, Eckman C . Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A. 2003; 100(10):6221-6. PMC: 156353. DOI: 10.1073/pnas.1031520100. View

19.

Alper B, Nienow T, Schmidt W . A common genetic system for functional studies of pitrilysin and related M16A proteases. Biochem J. 2006; 398(1):145-52. PMC: 1525005. DOI: 10.1042/BJ20060311. View

20.

Goode D, Totten R, Heeres J, Hergenrother P . Identification of promiscuous small molecule activators in high-throughput enzyme activation screens. J Med Chem. 2008; 51(8):2346-9. DOI: 10.1021/jm701583b. View